|
SteinCares inks strategic licensing agreement with Shilpa Biologicals> |
|
Shilpa Medicare's biopharma subsidiary inks licensing agreement with SteinCares for Latin America> |
|
Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG> |
|
Shilpa Medicare submits ANDA for Rotigotine transdermal patch> |
|
Shilpa Medicare consolidated net profit rises 40.28% in the December 2025 quarter> |
|
Easy Trip Planners Ltd leads gainers in 'A' group> |
|
Shilpa Medicare to convene board meeting> |
|
Shilpa Medicare receives initial authorization from Europe for Rotigotine Transdermal Patch> |
|
Shilpa Medicare receives eight USFDA observations for Jadcherla facility> |
|
Shilpa Medicare's Unit IV completes USFDA inspection> |